{"nct_id":"NCT04430738","title":"Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2020-09-15","start_date_type":"ACTUAL","primary_completion_date":"2024-07-31","primary_completion_date_type":"ACTUAL","completion_date":"2025-09-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PFE"]}